Charles H. Sherwood, CEO and Director at Anika Therapeutics, Inc. (ANIK), sold 6,556 shares at $60.04 ($394K) on 2017-10-24, disclosed to the SEC on 2017-10-26.
Open-market sale of $394k ANIK by CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.04 | 3,278 | $197K | 50.0% |
| 2 | $60.04 | 3,278 | $197K | 50.0% |
| Total | $60.04 avg | 6,556 | $394K | 100% |
| Filing → |
| ANIK | SELL | 2017-10-16 | $742K | — | Filing → |
| ANIK | SELL | 2017-07-31 | $6.5M | — | Filing → |
| ANIK | SELL | 2017-07-06 | $1.1M | — | Filing → |